Folgen
-
Dr. Daniela S. Gerhard’s passion for science and robust work ethic were legendary in the cancer genomics research community. But lesser known were Daniela’s devotion to building collaborations, compassion for colleagues and patients, and goulash. Colleagues and friends reflect on Daniela’s work and legacy at the National Cancer Institute.
-
Kenneth L. Scott was a cancer genomics researcher for NCI’s Cancer Target Discovery and Development (CTD2) program and a professor at Baylor College of Medicine. Also, he wanted to be a honey badger. Colleagues and friends discuss Ken’s grand vision for precision oncology, his experience with rare cancer, and his unique relationship with the honey badger.
-
Fehlende Folgen?
-
Research is hard. Having a family is hard. Cancer researchers at different stages of their lives—in terms of both family and career—discuss their struggles, achievements, and outlook.
-
Dr. Denise Wolf tells the story of her serendipitous path from electrical engineering to precision oncology research, and why studying something interesting was not enough.
-
In the mid-1990s, the idea of a genome-scale study seemed impossible or even crazy to some. Dr. Lou Staudt (director of NCI’s Center for Cancer Genomics) talks about putting together one of the first cancer genomic studies for diffuse large B-cell lymphoma and building the “Lymphochip” microarray.
-
Welcome to Personal Genomics, a podcast from the Center for Cancer Genomics at the National Cancer Institute. In upcoming episodes, you’ll hear personal stories from researchers about what really motivates them to work in one of the most complex areas of cancer research. Listen to our trailer to get a taste of what’s to come.
